Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2024 Nov 14;10(1):2419779. doi: 10.1080/20565623.2024.2419779

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2024 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group

This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent.

PMC Copyright notice

Figure 5. — Statistical analysis in each biomarker regarding the efficacy of HDM SLIT for patients with AD with allergic rhinitis.

(A, B, D–I) Significant differences in data before treatment and at 24 months follow-up. The Friedman test was used for comparisons of three groups. (C) Significant differences in data before treatment and at 12months follow-up. The Wilcoxon matched pairs signed rank test was used to compare two groups.

Der p s-IgE: Dermatophagoides pteronyssinus specific-IgE; Der p s-IgG4: Dermatophagoides farinae specific-IgG4; Der f s-IgE: Dermatophagoides farinae specific-IgE; Der f s-IgG4: Dermatophagoides farinae specific-IgG4; IgE: Immunoglobulin E; IgG4: Immunoglobulin G subclass 4; TARC: Thymus and activation-regulated chemokine.